Weekly Injectable Breakthrough for Type 2 Diabetes Shows Promising Blood Sugar & Weight Loss in Phase 3 Trial
A new weekly injectable drug for type 2 diabetes and obesity has just entered Phase 3 trials, outperforming Ozempic and Wegovy in blood sugar control and weight loss—yet its path ... Read More